Glucose or Insulin, Which Is Culprit in Patients with COVID-19 and Diabetes?

 Marc Y. Donath

DOI:https://doi.org/10.1016/j.cmet.2020.11.015

PDF: https://www.cell.com/action/showPdf?pii=S1550-4131%2820%2930648-3

Patients with a metabolic syndrome (overweight, diabetes, hypertension, and dyslipidemia) have a particularly bad outcome if infected with SARS-CoV-2. 

Yu et al. (2020)

 suggest that insulin therapy itself may promote fatality in patients with COVID-19 and diabetes.

https://www.cell.com/cell-metabolism/fulltext/S1550-4131(20)30648-3#secsectitle0010